Analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
AssigneePurdue Pharma L.P.
InventorsRonald M. Burch, Paul D. Goldenheim, Richard S. Sackler
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a combination of an opioid analgesic together with a COX-2 inhibitor.
Claims29
A pharmaceutical composition comprising a combination of a COX-2 inhibitor in an amount sufficient to render a therapeutic effect together with an opioid analgesic, except for combinations of the COX-2 inhibitor with an anti-tussive dose of hydrocodone or codeine.
A method of effectively treating pain in humans or other mammals, comprising administering to the patient a therapeutically effective amount of a COX-2 inhibitor together with a dose of an opioid analgesic.
The use of a pharmaceutical combination of a COX-2 inhibitor together with an opioid analgesic to provide effective pain management in humans.
The use of a COX-2 inhibitor in the manufacture of a pharmaceutical preparation containing a COX-2 inhibitor and an opioid analgesic for the treatment of pain.
The use of an opioid analgesic in the manufacture of a pharmaceutical preparation containing a COX-2 inhibitor and an opioid analgesic for the treatment of pain.
A method of reducing the amount of opioid required to treat a patient affected with pain comprising co-administering with said opioid analgesic an effective amount of a COX-2 inhibitor, to augment the analgesia attributable to said opioid analgesic during at least a portion of the dosage interval of said opioid analgesic.
A method of reducing the amount of a COX-2 inhibitor required to treat a patient affected with pain, comprising co-administering with said COX-2 inhibitor an effective amount of an opioid analgesic, to augment the analgesia attributable to said COX-2 inhibitor during at least a portion of the dosage interval of said COX-2 inhibitor.
Dependencies are inferred from the claim text.